[HTML][HTML] The Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A …
Q Liu, C Wang, P Li, J Liu, G Huang… - BioMed research …, 2016 - hindawi.com
Purpose. We performed this meta-analysis to determine the utilities of 18 F-FDG PET/CT
and MRI in assessing the pathological complete response (pCR) after neoadjuvant …
and MRI in assessing the pathological complete response (pCR) after neoadjuvant …
18F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients
Purpose Pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) is commonly
accepted as the gold standard to assess outcome after NAC in breast cancer patients. F…
accepted as the gold standard to assess outcome after NAC in breast cancer patients. F…
[PDF][PDF] Breast-specific gamma camera imaging with Tc-MIBI has better diagnostic performance than magnetic resonance imaging in breast cancer patients: A meta …
A Zhang, P Li, Q Liu, S Song - Hellenic journal of nuclear medicine, 2017 - nuclmed.gr
… Panli Li, MD, … Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD et al.
Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human …
Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human …
Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis
P Li, Q Liu, C Wang, T Wang, J Liu, G Huang… - Annals of nuclear …, 2016 - Springer
We aimed to explore the diagnostic accuracy of 18 F-fluorodeoxyglucose positron emission
tomography ( 18 F-FDG PET) for detection of gastric cancer recurrence after surgical …
tomography ( 18 F-FDG PET) for detection of gastric cancer recurrence after surgical …
CaCO3‐Encapuslated Microspheres for Enhanced Transhepatic Arterial Embolization Treatment of Hepatocellular Carcinoma
A Zhang, Z Xiao, Q Liu, P Li, F Xu, J Liu… - Advanced …, 2021 - Wiley Online Library
Transcatheter arterial embolization (TAE) is an extensively applied treatment method for
hepatocellular carcinoma (HCC). However, the worsened tumor microenvironment (TME, eg, …
hepatocellular carcinoma (HCC). However, the worsened tumor microenvironment (TME, eg, …
[HTML][HTML] 131I-labeled copper sulfide-loaded microspheres to treat hepatic tumors via hepatic artery embolization
Q Liu, Y Qian, P Li, S Zhang, J Liu, X Sun, M Fulham… - Theranostics, 2018 - ncbi.nlm.nih.gov
Purpose: Transcatheter hepatic artery embolization therapy is a minimally invasive alternative
for treating inoperable liver cancer but recurrence is frequent. Multifunctional agents, …
for treating inoperable liver cancer but recurrence is frequent. Multifunctional agents, …
[HTML][HTML] A core-shell Au@Cu2-xSe heterogeneous metal nanocomposite for photoacoustic and computed tomography dual-imaging-guided photothermal boosted …
L Zhang, C Jiang, B Li, Z Liu, B Gu, S He, P Li… - Journal of …, 2021 - Springer
Chemodynamic therapy (CDT) has aroused extensive attention for conquering cancers
because of its high specificity and low invasiveness. Quick generation of hydroxyl radicals (·OH) …
because of its high specificity and low invasiveness. Quick generation of hydroxyl radicals (·OH) …
Highly tumor-specific and long-acting iodine-131 microbeads for enhanced treatment of hepatocellular carcinoma with low-dose radio-chemoembolization
Y Qian, Q Liu, P Li, Y Han, J Zhang, J Xu, J Sun, A Wu… - ACS …, 2021 - ACS Publications
Transarterial radioembolization (TARE) is considered the standard treatment for intermediate-stage
hepatocellular carcinoma (HCC). Iodine-131 ( 131 I)-labeled lipiodol TARE is an …
hepatocellular carcinoma (HCC). Iodine-131 ( 131 I)-labeled lipiodol TARE is an …
[HTML][HTML] The combined therapeutic effects of 131iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer
Q Liu, Y Qian, P Li, S Zhang, Z Wang, J Liu… - … pharmaceutica sinica B, 2018 - Elsevier
Compared to conventional cancer treatment, combination therapy based on well-designed
nanoscale platforms may offer an opportunity to eliminate tumors and reduce recurrence and …
nanoscale platforms may offer an opportunity to eliminate tumors and reduce recurrence and …
[HTML][HTML] Optimal 18F-FDG PET/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: a multicentric study
Y Zuo, Q Liu, N Li, P Li, J Zhang, S Song - Frontiers in Oncology, 2023 - frontiersin.org
Purpose: To develop and interpret optimal predictive models to identify epidermal growth
factor receptor (EGFR) mutation status and subtypes in patients with lung adenocarcinoma …
factor receptor (EGFR) mutation status and subtypes in patients with lung adenocarcinoma …